fig3
![Molecular vulnerabilities and therapeutic resistance in hormone receptor positive and HER2 dependent breast cancer tumours](https://image.oaes.cc/9677304d-3c76-4737-9afe-ba4000823eb6/4769.fig.3.jpg)
Figure 3. Schematic representation of RAS-mediated TORC1 activation by both PI3K and MAPK pathways. Figure used from Sudhan et al.[21].
Figure 3. Schematic representation of RAS-mediated TORC1 activation by both PI3K and MAPK pathways. Figure used from Sudhan et al.[21].
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/